Catalog #SK11
Selank
10 MG
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$40.00
Technical Research Description
Selank is a synthetic heptapeptide created by combining the immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro sequence. It exhibits anxiolytic properties through GABAergic system modulation, enhances BDNF expression, and demonstrates immunomodulatory effects via cytokine regulation in research models.
Simplified Explanation
Selank combines an immune-supporting peptide with additional amino acids to create a compound that affects both brain function and immunity. Scientists study how it reduces anxiety-like behaviors, improves learning, and balances immune responses without causing sedation or dependence.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Certificate of Analysis (COA)
THIRD-PARTY VERIFIEDIndependent third-party HPLC and mass spectrometry analysis is provided for every batch.
Customer Reviews
No reviews yet — be the first to share your experience.
Frequently bought together
Related Research Peptides
From Our Research Blog
Background reading and laboratory context for Selank 10 MG — sourced from our research articles.
research
Selank and the neuropeptide logic of calm cognition
Selank is a tuftsin-derived research peptide studied for anxiety-linked cognition, GABAergic signaling, and neuroimmune crosstalk …
Sep 14, 2026
research
Selank: what researchers track in anxiety circuits
A research-first look at Selank (SK11): proposed targets, preclinical signals, and practical assay ideas for labs studying stress …
Aug 12, 2026
research
Selank in cognitive research: calm focus, mechanistically
Selank is a neuroactive research peptide studied for stress-linked cognition. Here's what preclinical literature suggests about it…
Jul 12, 2026
research
Semax: A neuropeptide probe for plasticity signals
Semax is studied as a melanocortin-derived neuropeptide that may shift BDNF-linked signaling in preclinical models. Here's how lab…
Oct 1, 2026
research
Epithalon and telomeres: what the data suggests
A research-first look at Epithalon: telomerase signals, circadian biology, and why mechanistic claims outpace the best preclinical…
Sep 27, 2026
research
Selank cognitive research peptide: what we know now
Selank has shown anxiolytic-like and cognition-adjacent signals in preclinical studies. Here's what the literature supports-and wh…
Sep 23, 2026